You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《瑞通窝轮》瑞通认股证牛熊证恒指未跟随美股反弹即市有资金留意牛证美团高位整固恒指牛53889熊53112/美团最高收回价牛54039/友邦购19276沽21926
阿思达克 08-27 10:33

美国总统特朗普表示,中方致电要求重返谈判桌,道指隔晚回升269点(或1%),收报25898点。

中美互相加徵关税,离岸人民币跌至历史新低,拖累恒指昨曾泻逾900点,低见25249点,尾市跌幅收窄,收报25680点,跌499点(或1.9%)。恒指今早稍作反弹,重上25700点水平,惟其後由升转跌。恒指好仓(牛证及认购权证)昨净流入逾6100万港元(下同),恒指淡仓(熊证及认沽权证)同日净流出逾1.1亿元,反映投资者预期大市急挫後将见技术性反弹。昨日恒指牛证街货重货区为收回价25000至25099点,而熊证街货重货区为收回价26400至26499点。

友邦(01299)是昨日其中一只拖低大市的重磅蓝筹,即市曾挫4.7%见74.05元,其後跌幅收窄至不足3%收市,报75.5元,但连失10天和20天线。股份今早继续向下,跌逾1%,观察早前底位约72.5元之支持力,此亦是现时250天线所在之处。昨有逾120万元净流入其好仓,淡仓同日则有近210万元净流出。

美团点评(03690)上季度首次实现盈利,获多间券商唱好,股价昨在大成交下逆市抽升近9%,盘中高位升抵77元创上市新高,14日RSI进入超买水平。美团今早於高位偏软整固,暂於75.5元附近水平徘徊,技术走势继续向好。美团下月二十日上市一周年,亦是控股股东股份禁售期届满之时,或为股价後市带来影响。昨有近640万元净流出其好仓,淡仓同日则有100万元净流入。

中国平安(02318)之港股通,昨录2.11亿元北水净流入。股份昨曾下挫3.4%至88.65元,其後获买盘承接,收市跌幅收窄至1.42%,10天、20天线、以及90元关口失而复得。股份今早续於90元附近徘徊,约92.4元的50天线暂为上升阻力。消息方面,平保旗下金融壹帐通将夥欧洲科技服务供应商进军欧洲。昨有375万元净流入平保好仓,淡仓同日则有逾320万元净流出。

内地新修订的《中华人民共和国药品管理法》获表决通过,将於12月1日起实施。据报新法对临床急需的短缺药、防治重大传染病和罕见病等疾病的新药、儿童用药开设绿色通道,优先审评审批。医药股昨日逆市企稳,石药(01093)昨低见14.8元大幅反弹,收市倒升0.8%报15.82元,连升八个交易日,累计升幅超过32%。石药今早上试15.9元,14日RSI续处超买水平。昨有8万元净流出其好仓,淡仓同日则有15万元净流入。

瑞通相关认股证之选择:

友邦轻微价外、短期购19276,行使价:79.93元,2019年10月到期,实际杠杆:14.6倍

友邦贴价、中短期沽21926,行使价:72.83元,2019年12月到期,实际杠杆:7.5倍

美团轻微价外、中短期购20429,行使价:80元,2020年2月到期,实际杠杆:4.6倍

平保轻微价外、中短期购23692,行使价:99.98元,2020年2月到期,实际杠杆:9.9倍

平保贴价、极短期沽16665,行使价:88.88元,2019年10月到期,实际杠杆:13.7倍

石药轻微价外、短期购14809,行使价:17.28元,2019年11月到期,实际杠杆:6.6倍

南中A50轻微价外、中短期购18962,行使价:15.4元,2020年1月到期,实际杠杆:10.2倍

南中A50轻微价外、中短期沽28645,行使价:13.06元,2019年12月到期,实际杠杆:9.1倍

中移轻微价外、中短期购19716,行使价:69.88元,2019年12月到期,实际杠杆:14.2倍

建行轻微价外、中短期购21933,行使价:6.38元,2020年2月到期,实际杠杆:11.2倍

工行轻微价外、中短期购21927,行使价:5.38元,2020年2月到期,实际杠杆:10.5倍

瑞通相关牛熊证之选择:

恒指牛证53889,收回价:25010点,杠杆比率:37.7倍

恒指熊证53112,收回价:26380点,杠杆比率:26.2倍

友邦牛证57802,收回价:70.07元,杠杆比率:12.9倍

友邦熊证52302,收回价:81.6元,杠杆比率:9倍

美团牛证54039,收回价:63.1元,杠杆比率:4.5倍

平保牛证58020,收回价:84.6元,杠杆比率:12.7倍

平保熊证52305,收回价:94.9元,杠杆比率:14.6倍重要风险通知

本结构性产品并无抵押品。

结构性产品之价格一般可急升亦可急跌,有可能损失结构性产品之全部或重大部分购买价,阁下对此应有所准备。

阁下投资前应了解产品风险,如有需要应谘询专业建议。~重要声明:

以上资讯由第三方提供,AASTOCKS.com Limited对於任何包含於、经由、连结、下载或从任何与本网站有关服务所获得之资讯、内容或广告,不声明或保证其内容之正确性或可靠性。对於您透过本网站上之广告、资讯或要约而展示、购买或取得之任何产品、资讯资料,本公司亦不负品质保证之责任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account